<div><ul><li>A minimum of one company representative is required for the company template.</li><li>There must be a company representative associated with each of the following roles: “Manufacturer / Sponsor Contact”, “Billing Contact”, “Regulatory Mailing / Annual Contact” and “Primary REP Contact”.</li><li>A single contact may be associated with multiple roles, however, each role may only have one contact.</li><li>The Primary REP contact is the person to be contacted by Health Canada if there are any issues or clarifications required for this template when it is submitted for approval.</li><li>Sponsors may choose to provide an Alternate REP contact, however this is not a requirement.</li><br>Description of Roles<br><li>“Manufacturer / Sponsor Information”: Refers to the name to which the drug submission is filed and, where a Drug Identification Number (DIN) / Notice of Compliance (NOC) is to be issued, the company in whose name the DIN / NOC will be registered, (i.e., the DIN / NOC owner) and the name to be included on the product label and Product Monograph / Package Insert.</li><li>“Regulatory Mailing / Annual Contact”: pertains to where and to whom Health Canada should direct regulatory mail other than correspondence specific to the subject drug submission, e.g. annual notification, regulatory / policy amendment notices as they apply to DINs registered to the manufacturer/sponsor. Operational and system requirements dictate that the regulatory mailing name/address must be the same for all DINs registered to the manufacturer / sponsor identified where more than one DIN is held by that company.</li><li>“Billing Address” – To whom the invoice is to be sent.</li></ul></div>